Evidence map›Paper›PMID 33046553›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2020

MeCP2 Levels Regulate the 3D Structure of Heterochromatic Foci in Mouse Neurons.

Aya Ito-Ishida, Steven A Baker, Roy V Sillitoe, Yaling Sun, Jian Zhou, Yukiteru Ono, Junichi Iwakiri, Michisuke Yuzaki, Huda Y Zoghbi

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. MeCP2 is a naturally supercharged protein with cell membrane transduction capabilities.Protein science : a publication of the Protein Society · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. MeCP2 regulateseLife · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Aya Ito-IshidaDepartment of Molecular and Human Genetics hzoghbi@bcm.edu aishida@keio.jp.ORCID 0000-0001-5531-2480
Steven A BakerDepartment of Molecular and Human Genetics.
Roy V SillitoeDepartment of Neuroscience.
Yaling SunDepartment of Molecular and Human Genetics.
Jian ZhouDepartment of Molecular and Human Genetics.
Yukiteru OnoDepartment of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8561, Japan.
Junichi IwakiriDepartment of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8561, Japan.
Michisuke YuzakiDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Huda Y ZoghbiDepartment of Molecular and Human Genetics hzoghbi@bcm.edu aishida@keio.jp.ORCID 0000-0002-0700-3349
Baylor College of Medicine · USThe University of Tokyo · JPHoward Hughes Medical Institute · USKeio University · JP

Funding

Preclinical and Clincial OutcomesP50HD103555 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI Sandesh Chakravarthy Sreenath Nagamani, David Loren Nelson · 2020 to 2026
$9.9M
Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, NEUL, JEFFREY L · 2014 to 2019
$7.8M
MOLECULAR PATHOGENESIS STUDIES OF RETT SYNDROMER01NS057819 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ZOGHBI, HUDA Y · 2006 to 2025
$7.5M
SYNAPTIC ORIGINS OF CEREBELLAR DISEASER01NS089664 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI SILLITOE, ROY VINCENT · 2014 to 2018
$1.7M
Howard Hughes Medical InstituteNICHD NIH HHS P50 HD103555NICHD NIH HHS U54 HD083092NINDS NIH HHS R01 NS057819NINDS NIH HHS R01 NS089664
6 · The paper itself

Abstract

Methyl-CpG binding protein 2 (MeCP2) is a nuclear protein critical for normal brain function, and both depletion and overexpression of MeCP2 lead to severe neurodevelopmental disease, Rett syndrome (RTT) and

Indexed as

Methyl-CpG-Binding Protein 2AnimalsCell NucleolusCerebral CortexChromatinCodon, NonsenseDevelopmental DisabilitiesFemaleHistonesMaleMiceMice, Inbred C57BLMice, KnockoutNeuronsProtein BindingProtein Structure, TertiaryChromatinCodon, NonsenseHistonesMecp2 protein, mouseMethyl-CpG-Binding Protein 2chromatinimagingMeCP2neuronRett syndrome

Identifiers

PMID33046553
PMCPMC7643291
OpenAlexW3092026062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.